These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 20304746)

  • 21. [What is new in the treatment of diabetes mellitus?].
    Gain T
    Krankenpfl J; 2000 Oct; 38(9-10):328-31. PubMed ID: 11194350
    [No Abstract]   [Full Text] [Related]  

  • 22. Type II diabetes: insulin versus oral agents.
    Martin DB
    N Engl J Med; 1986 May; 314(20):1314-5. PubMed ID: 3517646
    [No Abstract]   [Full Text] [Related]  

  • 23. Starting insulin therapy in type 2 diabetes: lesson 2.
    McCall AL
    Curr Diab Rep; 2005 Oct; 5(5):326-8. PubMed ID: 16188165
    [No Abstract]   [Full Text] [Related]  

  • 24. At last, a weight neutral insulin?
    Fritsche A; Häring H
    Int J Obes Relat Metab Disord; 2004 Sep; 28 Suppl 2():S41-6. PubMed ID: 15306837
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of diabetes mellitus on glomerular filtration rate in an urban hospital diabetic population.
    Odutola TA; Mabadeje AF; Mabayoje MO
    Afr J Med Med Sci; 1997; 26(1-2):19-21. PubMed ID: 10895222
    [TBL] [Abstract][Full Text] [Related]  

  • 26. New Insulin Options for Diabetic Patients.
    Van Klompenburg E; Heins JR
    S D Med; 2016 Feb; 69(2):84-5. PubMed ID: 26999916
    [No Abstract]   [Full Text] [Related]  

  • 27. Optimizing insulin therapy in patients with type 1 and type 2 diabetes mellitus: optimal dosing and timing in the outpatient setting.
    Hahr AJ; Molitch ME
    Am J Ther; 2008; 15(6):543-50. PubMed ID: 19127139
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [From insulin secretion to insulin therapy].
    Soltani D; Perlemuter L
    Presse Med; 1998 Jul 4-11; 27(24):1240-6. PubMed ID: 9767787
    [No Abstract]   [Full Text] [Related]  

  • 29. [Care of people with diabetes in the pharmacy].
    Müller U
    Pharm Unserer Zeit; 2012 Jul; 41(4):313-22. PubMed ID: 22764001
    [No Abstract]   [Full Text] [Related]  

  • 30. A failure to communicate.
    Curry A
    Diabetes Forecast; 2014 Jan; 67(1):92-3. PubMed ID: 25868303
    [No Abstract]   [Full Text] [Related]  

  • 31. [The guidance of the diabetic patient before and following surgery].
    Petzoldt R; Schöffling K
    Med Klin; 1971 Sep; 66(37):1221-5. PubMed ID: 4936589
    [No Abstract]   [Full Text] [Related]  

  • 32. The use of insulin in cystic fibrosis-related diabetes: a philosophical difference from the use of insulin in type 1 and type 2 diabetes.
    Bremer AA
    Pediatr Pulmonol; 2012 Nov; 47(11):1039-41. PubMed ID: 22911489
    [No Abstract]   [Full Text] [Related]  

  • 33. [Diabetes. Thanks to the treatment, the role of the patient becomes clear].
    Ardilouze JL
    Union Med Can; 1992; 121(6):389, 392-6. PubMed ID: 1481300
    [No Abstract]   [Full Text] [Related]  

  • 34. Impact of insulin delivery devices in diabetes care.
    Garg SK
    Diabetes Technol Ther; 2010 Jun; 12 Suppl 1():S1-3. PubMed ID: 20515296
    [No Abstract]   [Full Text] [Related]  

  • 35. [New-onset type 1 diabetes: what to do, differential diagnosis and prevention].
    Achenbach P; Hummel M
    MMW Fortschr Med; 2011 May; 153(20):45-7. PubMed ID: 21644293
    [No Abstract]   [Full Text] [Related]  

  • 36. [Escaping oral hypoglycemic agents in type 2 diabetes: importance and limitations of transitory optimized insulin therapy].
    Leutenegger M; Bertin E; Grulet H
    Diabetes Metab; 1998 Feb; 24(1):80-4. PubMed ID: 9534015
    [No Abstract]   [Full Text] [Related]  

  • 37. The reality of glycaemic control in insulin treated diabetes: defining the clinical challenges.
    Davies M
    Int J Obes Relat Metab Disord; 2004 Sep; 28 Suppl 2():S14-22. PubMed ID: 15306833
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Diabetic patients under thirty years of age treated orally].
    Schrub JC; Vuillermet P; Doucet J
    Sem Hop; 1982 Oct; 58(37):2147-8. PubMed ID: 6294851
    [No Abstract]   [Full Text] [Related]  

  • 39. Treatment of type 2 diabetes with combined therapy: what are the pros and cons?
    Massi-Benedetti M; Orsini-Federici M
    Diabetes Care; 2008 Feb; 31 Suppl 2():S131-5. PubMed ID: 18227473
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pathophysiology of type 1 and type 2 diabetes mellitus: a 90-year perspective.
    Zaccardi F; Webb DR; Yates T; Davies MJ
    Postgrad Med J; 2016 Feb; 92(1084):63-9. PubMed ID: 26621825
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.